 LONDON and REDWOOD CITY, Calif., Nov. 10, 2020 GLOBE NEWSWIRE -- Mereo BioPharma Group plc NASDAQ: MREO, AIM: MPH Mereo or the Company, a clinical stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo will present at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020 at 11:20am Eastern Time. 